Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v3.21.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2018 $ 110 $ 108,600 $ (107,200) $ 1,510
Balances at beginning (in shares) at Dec. 31, 2018 11,018,364      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cumulative adjustment for adoption of new accounting standard
Share-based compensation $ 2 797   799
Share-based compensation (in shares) 194,694      
Warrant and option exercises $ 16 373   389
Warrant and option exercises (in shares) 1,595,795      
May 2019 private placement, net of offering costs $ 24 7,404   7,428
May 2019 private placement, net of offering costs (in shares) 2,426,455      
Net loss for the period     (5,540) (5,540)
Balances at ending at Dec. 31, 2019 $ 152 117,174 (112,740) 4,586
Balance at ending (in shares) at Dec. 31, 2019 15,235,308      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
2020 senior secured convertible note beneficial conversion feature   3,107   3,107
Share-based compensation $ 3 1,087   1,090
Share-based compensation (in shares) 267,608      
Warrant and option exercises $ 15 361   376
Warrant and option exercises (in shares) 1,544,668      
Net loss for the period     (6,782) (6,782)
Balances at ending at Dec. 31, 2020 $ 170 $ 121,729 $ (119,522) $ 2,377
Balance at ending (in shares) at Dec. 31, 2020 17,047,584